4.4 Article

Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium

期刊

SURGERY FOR OBESITY AND RELATED DISEASES
卷 11, 期 5, 页码 1109-1118

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2015.01.011

关键词

Bariatric surgery; Weight change; Predictors; LABS; Cohort study; Diabetes

类别

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK066557, U01-DK66667, UL1-RR024996, U01-DK66568, M01RR-00037, U01-DK66471, U01-DK66526, U01-DK66585, UL1-RR024153, U01-DK66555]

向作者/读者索取更多资源

Background: Limited data guide the prediction of weight loss success or failure after bariatric surgery according to presurgery factors. There is significant variation in weight change after bariatric surgery and much interest in identifying preoperative factors that may contribute to these differences. This report evaluates the associations of a comprehensive set of baseline factors and 3-year weight change. Setting: Ten hospitals in 6 geographically diverse clinical centers in the United States. Methods: Adults undergoing a first bariatric surgical procedure as part of clinical care by participating surgeons were recruited between 2006 and 2009. Participants completed research assessments utilizing standardized and detailed data collection on over 100 preoperative and operative parameters for individuals undergoing Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB). Weight was measured 3 years after surgery. Percent weight change for RYGB or LAGB from baseline to 3 years was analyzed as both a continuous and dichotomous outcome with cut points at 25% for RYGB and 10% for LAGB. Multivariable linear and logistic regression models were used to identify independent baseline predictors of the continuous and categorical outcomes, respectively. Results: The median weight loss 3 years after surgery for RYGB (n = 1513) participants was 31.5% (IQR: 24.6%-38.4%; range, 59.2% loss to .9% gain) of baseline weight and 16.0% (IQR: 8.1%-23.1%; range, 56.1% loss to 12.5% gain) for LAGB (n = 509) participants. The median age was 46 years for RYGB and 48 years for LAGB; 80% of RYGB participants and 75% of LAGB participants were female; and the median baseline body mass index (BMI) was 46 kg/m(2) for RYGB and 44 kg/m(2) for LAGB. For RYGB, black participants lost 2.7% less weight compared with whites and participants with diabetes at baseline had 3.7% less weight loss at year 3 than those without diabetes at baseline. There were small but statistically significant differences in weight change for RYGB in those with abnormal kidney function and current or recent smoking. For LAGB participants, those with a large band circumference had 75% greater odds of experiencing less than 10% weight loss after adjusting for BMI and sex. Conclusions: Few baseline variables were associated with 3-year weight change and the effects were small. These results indicate that baseline variables have limited predictive value for an individual's chance of a successful weight loss outcome after bariatric surgery. (C) 2015 American Society for Metabolic and Bariatric Surgery. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

CD40 promotes MHC class II expression on adipose tissue macrophages and regulates adipose tissue CD4+ T cells with obesity

David L. Morris, Kelsie E. Oatmen, Taleen A. Mergian, Kae Won Cho, Jennifer L. DelProposto, Kanakadurga Singer, Carmella Evans-Molina, Robert W. O'Rourke, Carey N. Lumeng

JOURNAL OF LEUKOCYTE BIOLOGY (2016)

Article Immunology

Adipose Tissue Dendritic Cells Are Independent Contributors to Obesity-Induced Inflammation and Insulin Resistance

Kae Won Cho, Brian F. Zamarron, Lindsey A. Muir, Kanakadurga Singer, Cara E. Porsche, Jennifer B. DelProposto, Lynn Geletka, Kevin A. Meyer, Robert W. O'Rourke, Carey N. Lumeng

JOURNAL OF IMMUNOLOGY (2016)

Article Endocrinology & Metabolism

Adipose Tissue Fibrosis, Hypertrophy, and Hyperplasia: Correlations with Diabetes in Human Obesity

Lindsey A. Muir, Christopher K. Neeley, Kevin A. Meyer, Nicki A. Baker, Alice M. Brosius, Alexandra R. Washabaugh, Oliver A. Varban, Jonathan F. Finks, Brian F. Zamarron, Carmen G. Flesher, Joshua S. Chang, Jennifer B. DelProposto, Lynn Geletka, Gabriel Martinez-Santibanez, Niko Kaciroti, Carey N. Lumeng, Robert W. O'Rourke

OBESITY (2016)

Article Endocrinology & Metabolism

Does bariatric surgery improve adipose tissue function?

H. Frikke-Schmidt, R. W. O'Rourke, C. N. Lumeng, D. A. Sandoval, R. J. Seeley

OBESITY REVIEWS (2016)

Article Endocrinology & Metabolism

Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice

Henriette Frikke-Schmidt, Brian F. Zamarron, Robert W. O'Rourke, Darleen A. Sandoval, Carey N. Lumeng, Randy J. Seeley

MOLECULAR METABOLISM (2017)

Article Endocrinology & Metabolism

Adipocyte hypertrophy-hyperplasia balance contributes to weight loss after bariatric surgery

Lindsey A. Muir, Nicki A. Baker, Alexandra R. Washabaugh, Christopher K. Neeley, Carmen G. Flesher, Jennifer B. DelProposto, Lynn M. Geletka, Amir A. Ghaferi, Jonathan F. Finks, Kanakadurga Singer, Oliver A. Varban, Carey N. Lumeng, Robert W. O'Rourke

ADIPOCYTE (2017)

Article Endocrinology & Metabolism

Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes

Robert W. O'Rourke, Geoffrey S. Johnson, Jonathan Q. Purnell, Anita P. Courcoulas, Gregory F. Dakin, Luis Garcia, Marcelo Hinojosa, James E. Mitchell, Alfons Pomp, Walter J. Pories, Konstantinos Spaniolas, David R. Flum, Abdus S. Wahed, Bruce M. Wolfe

INTERNATIONAL JOURNAL OF OBESITY (2019)

Article Immunology

GM-CSF Administration Improves Defects in Innate Immunity and Sepsis Survival in Obese Diabetic Mice

Lynn M. Frydrych, Guowu Bian, Fatemeh Fattahi, Susan B. Morris, Robert W. O'Rourke, Carey N. Lumeng, Steven L. Kunkel, Peter A. Ward, Matthew J. Delano

JOURNAL OF IMMUNOLOGY (2019)

Article Chemistry, Multidisciplinary

Adipocyte Size Evaluation Based on Photoacoustic Spectral Analysis Combined with Deep Learning Method

Xiang Ma, Meng Cao, Qinghong Shen, Jie Yuan, Ting Feng, Qian Cheng, Xueding Wang, Alexandra R. Washabaugh, Nicki A. Baker, Carey N. Lumeng, Robert W. O'Rourke

APPLIED SCIENCES-BASEL (2018)

Article Biotechnology & Applied Microbiology

Regulation of adipose tissue inflammation and systemic metabolism in murine obesity by polymer implants loaded with lentiviral vectors encoding human interleukin-4

Richard Youngblood, Carmen G. Flesher, Jennifer Delproposto, Nicki A. Baker, Christopher K. Neeley, Fanghua Li, Carey N. Lumeng, Lonnie D. Shea, Robert W. O'Rourke

BIOTECHNOLOGY AND BIOENGINEERING (2020)

Review Endocrinology & Metabolism

Pathways to Severe COVID-19 for People with Obesity

Robert W. O'Rourke, Carey N. Lumeng

Summary: The increased morbidity and mortality of COVID-19 in individuals with obesity has drawn attention to the impaired responses to infections in this population. Research indicates a critical need to understand the physiological mechanisms underlying the increased risk for complications from COVID-19 in people with obesity, in order to develop tailored therapies for this group.

OBESITY (2021)

Article Endocrinology & Metabolism

Lumican modulates adipocyte function in obesity-associated type 2 diabetes

Strieder-Barboza, Carmen G. Flesher, Lynn Geletka, Tad Eichler, Olukemi Akinleye, Alexander P. Ky, Anne N. Ehlers, Carey W. Lumeng, Robert O'Rourke

Summary: Obesity-associated type 2 diabetes can lead to dysfunction in adipose tissue, and lumican, a proteoglycan, is involved in obesity, insulin resistance, and adipocyte dysfunction. In this study, lumican levels were found to be increased in visceral adipose tissue and adipocytes of individuals with DM. Knockdown of lumican in adipocytes led to decreased lipolysis and improved adipogenesis and insulin sensitivity in VAT adipocytes of DM patients, while treatment with human recombinant lumican increased lipolysis and impaired insulin-sensitivity through ERK signaling. This suggests that lumican can impair adipocyte metabolism, partly through ERK signaling, and may be a potential target for developing targeted therapeutics for adipose tissue in DM.

ADIPOCYTE (2022)

Article Endocrinology & Metabolism

Matrix density regulates adipocyte phenotype

Alexander Ky, Atticus J. Mccoy, Carmen G. Flesher, Nicole E. Friend, Jie Li, Kore Akinleye, Christopher Patsalis, Carey N. Lumeng, Andrew J. Putnam, Robert W. O'Rourke

Summary: The alterations of extracellular matrix contribute to dysfunction of adipose tissue in metabolic disease. In this study, we found that intermediate density matrix promotes more adipocyte generation, reduces fibrosis, and enhances lipid and aerobic metabolism.

ADIPOCYTE (2023)

Article Endocrinology & Metabolism

Diabetes-Specific Regulation of Adipocyte Metabolism by the Adipose Tissue Extracellular Matrix

Nicki A. Baker, Lindsey A. Muir, Alexandra R. Washabaugh, Christopher K. Neeley, Sophie Yu-Pu Chen, Carmen G. Flesher, John Vorwald, Jonathan F. Finks, Amir A. Ghaferi, Michael W. Mulholland, Oliver A. Varban, Carey N. Lumeng, Robert W. O'Rourke

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

暂无数据